11-10-2022 - SGLT2i: Evidence and Mechanisms for a Nephrology-Cardiology Consensus
Nephrology Grand Rounds: SGLT2 InhibitorsSee more
Dr. Mandeep Bajaj: Type 2 Diabetes, SGLT2 inhibitors and Heart FailureSee more
"SGLT2 Inhibitors: Mechanisms of Behind the Mortality Benefit" presented by Amy LiSee more
McGraw Hill Author Masterclass | SGLT2- Inhibitors | Dr. Sunder MudaliarSee more
SGLT2i for evidence based cardiorenal protection in diabetic and non-diabetic chronic kidney diseaseSee more
How SGLT2 Inhibitors Protect The KidneySee more
CWMGR: The Expanding Multiverse of SGLTi In & Beyond DiabetesSee more
CKD E-Learning - SGLT-2 inhibitors and CKD - 05.19.21See more
SGLT2 Inhibitors and Ketone Metabolism in Heart FailureSee more
SGLT2 Inhibitors for DiabeticsSee more
Role of SGLT2 Inhibitors in CKDSee more
A Tale of Salt and Sugar: SGLT2 Inhibitors in Cardiovascular DiseaseSee more
Dr Julie Lovshin - SGLT2i Cardiorenal mechanisms in diabetes and beyond - summary presentationSee more
SGLT2 Inhibitors: CV Outcomes Data in Type 2 DiabetesSee more
Protocols for Safe Use of SGLT2i and GLP1RA in the Hospital SettingSee more
Christine Limonte, MD - Update on SGLT2i: Real-world Use and Special PopulationSee more
What are SGLT2 inhibitors - Chronic Kidney Disease | UHL NHS TrustSee more
Addressing cardiorenal outcomes in CKD and T2D: What are the key considerations for daily practice?See more
Dr Julie Lovshin - SGLT2i Cardiorenal mechanisms in diabetes and beyond - full presentationSee more
